Maze Therapeutics, Inc.

MAZE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$30.37-3.53%

2026-11-02

Financials

Valuation Metrics

Maze Therapeutics, Inc.'s Market Cap is $1.68B. At end of 2025 it was $1.78B. Ranked #2081 of 3,116 in US market (top 67%), #801 of 1,472 on NASDAQ (top 54%), #146 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 55%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$1.68B	US#2,081/3,116 Sec#146/265
Revenue	$20M	US#2,788/3,116 Sec#161/265
Net Income	$-134M	US—/3,116 Sec—/265
Total Assets	$532M	US#2,732/3,116 Sec#155/265
Net Assets	$453M	US#2,284/3,116 Sec#117/265
Value
P/B	3.71x	US#2,015/3,116 Sec#120/265
P/S	84.04x	US#2,936/3,116 Sec#176/265
FCF Yield	-6.36%	US—/3,116 Sec—/265
Profitability
ROE	-29.48%	US#2,556/3,116 Sec#113/265
ROA	-25.13%	US#2,843/3,116 Sec#144/265
Op. Margin	-728.06%	US#2,793/3,116 Sec#160/265
Revenue Growth	700.00%	US#22/3,116 Sec#13/265
Financial Health
Debt Ratio	17.32%	US#194/3,116 Sec#71/265
Total Debt	$60M	US#2,560/3,116 Sec#147/265
FCF	$-107M	US#2,644/3,116 Sec#150/265
Cash	$203M	US#1,719/3,116 Sec#106/265
Current Ratio	18.31x	US#124/3,116 Sec#30/265
Performance
1Y Return	-7.72%	US#1,765/3,116 Sec#152/265
1M Return	14.91%	US#278/3,116 Sec#22/265
From 52W High	-43.39%	US#2,415/3,116 Sec#172/265
1Y MDD	-56.81%	US#2,642/3,116 Sec#191/265
Trading
Volume	317,890 shares	US#2,215/3,116 Sec#217/265
Trading Value	$10M	US#2,133/3,116 Sec#169/265
Per Share
EPS	$-2.41	US—/3,116 Sec—/265
BPS	$8.19	US#1,977/3,116 Sec#85/265